# Photothermal Effect of Gold Nanoparticles as a Nanomedicine for Diagnosis and Therapeutics

**Authors:** Panangattukara Prabhakaran Praveen Kumar, Dong-Kwon Lim

PMC · DOI: 10.3390/pharmaceutics15092349 · Pharmaceutics · 2023-09-19

## TL;DR

This paper reviews how gold nanoparticles' photothermal effect is used in medical diagnostics and treatments, including imaging and cancer therapy.

## Contribution

The paper highlights novel applications of gold nanoparticle photothermal effects in photoacoustic imaging, photonic PCR, and cancer immunotherapy.

## Key findings

- Gold nanoparticles' photothermal effect enhances photoacoustic signal intensity for better imaging.
- Integration of photothermal effects with PCR enables faster and more accurate DNA amplification.
- Controlled photothermal damage to cancer cells can stimulate immune responses for improved cancer treatment.

## Abstract

Gold nanoparticles (AuNPs) have received great attention for various medical applications due to their unique physicochemical properties. AuNPs with tunable optical properties in the visible and near-infrared regions have been utilized in a variety of applications such as in vitro diagnostics, in vivo imaging, and therapeutics. Among the applications, this review will pay more attention to recent developments in diagnostic and therapeutic applications based on the photothermal (PT) effect of AuNPs. In particular, the PT effect of AuNPs has played an important role in medical applications utilizing light, such as photoacoustic imaging, photon polymerase chain reaction (PCR), and hyperthermia therapy. First, we discuss the fundamentals of the optical properties in detail to understand the background of the PT effect of AuNPs. For diagnostic applications, the ability of AuNPs to efficiently convert absorbed light energy into heat to generate enhanced acoustic waves can lead to significant enhancements in photoacoustic signal intensity. Integration of the PT effect of AuNPs with PCR may open new opportunities for technological innovation called photonic PCR, where light is used to enable fast and accurate temperature cycling for DNA amplification. Additionally, beyond the existing thermotherapy of AuNPs, the PT effect of AuNPs can be further applied to cancer immunotherapy. Controlled PT damage to cancer cells triggers an immune response, which is useful for obtaining better outcomes in combination with immune checkpoint inhibitors or vaccines. Therefore, this review examines applications to nanomedicine based on the PT effect among the unique optical properties of AuNPs, understands the basic principles, the advantages and disadvantages of each technology, and understands the importance of a multidisciplinary approach. Based on this, it is expected that it will help understand the current status and development direction of new nanoparticle-based disease diagnosis methods and treatment methods, and we hope that it will inspire the development of new innovative technologies.

## Linked entities

- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Genes:** Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, PDCD1 (programmed cell death 1) [NCBI Gene 100533201], TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Itgax (integrin alpha X) [NCBI Gene 16411] {aka Cd11c, Cr4, N418}, CTLA4 (cytotoxic T-lymphocyte associated protein 4) [NCBI Gene 397286], Egfr (epidermal growth factor receptor) [NCBI Gene 13649] {aka 9030024J15Rik, Erbb, Errb1, Errp, Wa5, wa-2}, NCAM1 (neural cell adhesion molecule 1) [NCBI Gene 4684] {aka CD56, MSK39, NCAM}, Tlr7 (toll-like receptor 7) [NCBI Gene 170743], Cd80 (CD80 antigen) [NCBI Gene 12519] {aka B71, Cd28l, Ly-53, Ly53, MIC17, TSA1}, Hspa1b (heat shock protein family A (Hsp70) member 1B) [NCBI Gene 15511] {aka HSP70B1, Hsp70, Hsp70-1, Hsp70.1, hsp68}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, KLRK1 (killer cell lectin like receptor K1) [NCBI Gene 22914] {aka CD314, D12S2489E, KLR, NKG2-D, NKG2D}, Sell (selectin, lymphocyte) [NCBI Gene 20343] {aka CD62L, L-selectin, LAM-1, LECAM-1, LECAM1, Lnhr}, CD274 (CD274 molecule) [NCBI Gene 574058] {aka PDL1}, Pmel (premelanosome protein) [NCBI Gene 20431] {aka D10H12S53E, D12S53Eh, Pmel17, Si, Silv, gp100}, Ptprc (protein tyrosine phosphatase receptor type C) [NCBI Gene 19264] {aka B220, CD45R, Cd45, L-CA, Ly-5, Lyt-4}, AR (androgen receptor) [NCBI Gene 367] {aka AIS, AR8, DHTR, HPCX3, HUMARA, HYSP1}, CD274 (CD274 molecule) [NCBI Gene 29126] {aka ADMIO5, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1}, Ctla4 (cytotoxic T-lymphocyte-associated protein 4) [NCBI Gene 12477] {aka Cd152, Ctla-4, Ly-56}, Foxp3 (forkhead box P3) [NCBI Gene 20371] {aka JM2, scurfin, sf}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, Serpinb1-ps1 (serine (or cysteine) peptidase inhibitor, clade B, member 1, pseudogene) [NCBI Gene 282665] {aka EID, ovalbumin}, Cd86 (CD86 antigen) [NCBI Gene 12524] {aka B7, B7-2, B7.2, B70, CLS1, Cd28l2}, CD244 (CD244 molecule) [NCBI Gene 51744] {aka 2B4, NAIL, NKR2B4, Nmrk, SLAMF4}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, NCR2 (natural cytotoxicity triggering receptor 2) [NCBI Gene 9436] {aka CD336, LY95, NK-p44, NKP44, dJ149M18.1}, Stat3 (signal transducer and activator of transcription 3) [NCBI Gene 20848] {aka 1110034C02Rik, Aprf}, Grpr (gastrin releasing peptide receptor) [NCBI Gene 14829] {aka GRP-R}, NCR1 (natural cytotoxicity triggering receptor 1) [NCBI Gene 9437] {aka CD335, LY94, NK-p46, NKP46}, Clec7a (C-type lectin domain family 7, member a) [NCBI Gene 56644] {aka BGR, Clecsf12, beta-GR}, Cd274 (CD274 antigen) [NCBI Gene 60533] {aka A530045L16Rik, B7h1, Pdcd1l1, Pdcd1lg1, Pdl1}, NCR3 (natural cytotoxicity triggering receptor 3) [NCBI Gene 259197] {aka 1C7, CD337, LY117, MALS, NKp30}, Muc1 (mucin 1, transmembrane) [NCBI Gene 17829] {aka CD227, EMA, Muc-1}, Cd3e (CD3 antigen, epsilon polypeptide) [NCBI Gene 12501] {aka CD3, CD3epsilon, T3e}, Erbb2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 13866] {aka Erbb-2, HER-2, HER2, Neu, c-erbB2, c-neu}, HPD (4-hydroxyphenylpyruvate dioxygenase) [NCBI Gene 3242] {aka 4-HPPD, 4HPPD, GLOD3, HPPD, HPPDASE, PPD}, Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}, Il2 (interleukin 2) [NCBI Gene 16183] {aka Il-2}, Il2ra (interleukin 2 receptor, alpha chain) [NCBI Gene 16184] {aka CD25, Il2r, Ly-43}, Cd44 (CD44 antigen) [NCBI Gene 12505] {aka HERMES, Ly-24, Pgp-1}, Calr (calreticulin) [NCBI Gene 12317] {aka CRT, Calregulin}, Alb (albumin) [NCBI Gene 11657] {aka Alb-1, Alb1, BCL001, BCL002, BPL001}
- **Diseases:** colon carcinoma (MESH:D003110), cervical cancer (MESH:D002583), cutaneous squamous cell carcinoma (MESH:D002294), ICD (MESH:D003643), hepatocellular carcinoma (MESH:D006528), cytotoxicity (MESH:D064420), breast cancer (MESH:D001943), Cancer (MESH:D009369), COVID-19 (MESH:D000086382), necrosis (MESH:D009336), tumorigenic (MESH:D002471), AuNPs (MESH:D018467), lung cancer (MESH:D008175), injury to people or property (MESH:C000719191), glioblastoma astrocytoma (MESH:D005909), lung metastasis (MESH:D009362), bladder cancer (MESH:D001749), hypoxia (MESH:D000860), adenocarcinoma (MESH:D000230), arthritis (MESH:D001168), melanoma (MESH:D008545), gastric cancer (MESH:D013274), inflammatory (MESH:D007249), PTT (MESH:D016609), lung metastatic (MESH:D008171), apoptosis (MESH:D065703), colorectal cancer (MESH:D015179), damage (MESH:D020263), glioma tumors (MESH:D005910)
- **Chemicals:** DOX (MESH:D004317), imatinib mesylate (MESH:D000068877), PEG (MESH:D011092), 1V209 (MESH:C000710667), polymer (MESH:D011108), oxygen (MESH:D010100), peptide (MESH:D010455), SiO2 (MESH:D012822), atezolizumab (MESH:C000594389), oligonucleotide (MESH:D009841), phthalocyanine (MESH:C013647), iron (MESH:D007501), avelumab (MESH:C000609138), copper (MESH:D003300), cysteamine (MESH:D003543), polypyrrole (MESH:C067635), AP3 (MESH:C015682), 2-methacryloyloxyethyl phosphorylcholine (MESH:C070638), polydimethylsiloxane (MESH:C013830), mineral oils (MESH:D008899), polymethyl methacrylate (MESH:D019904), poly (diallyldimethylammonium chloride (MESH:C041004), captopril (MESH:D002216), AuNP (-), RGD (MESH:C047981), water (MESH:D014867), melanin (MESH:D008543), trastuzumab (MESH:D000068878), CaCO3 (MESH:D002119), PBS (MESH:D007854), hydrazine (MESH:C029424), cemiplimab (MESH:C000627974), chitosan (MESH:D048271), CTAB (MESH:D000077286), zinc oxide (MESH:D015034), copper sulfide (MESH:C017846), NO (MESH:D009614), Polysaccharide (MESH:D011134), indocyanine green (MESH:D007208), polyethylene glycol monomethyl ether (MESH:C028210), carbon (MESH:D002244), mannose (MESH:D008358), Porphyrin (MESH:D011166), Prussian Blue (MESH:C000170), durvalumab (MESH:C000613593), graphene (MESH:D006108), Thiol (MESH:D013438), hyaluronic acid (MESH:D006820), pembrolizumab (MESH:C582435), alpha-GalCer (MESH:C493154), monosaccharides (MESH:D009005), carbon nanotube (MESH:D037742), carbodiimide (MESH:D002234), poly (sodium 4-styrenesulfonate) (MESH:C077114), free radicals (MESH:D005609), Ag (MESH:D012834), Cy5 (MESH:C085321), imiquimod (MESH:D000077271), beta-1,3-glucans (MESH:C033363), Polydopamine (MESH:C568283)
- **Species:** Human immunodeficiency virus 1 (no rank) [taxon 11676], Homo sapiens (human, species) [taxon 9606], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** C in 5, C-55  C
- **Cell lines:** RAW264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), SK-BR-3 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0033), CT-26 — Mus musculus (Mouse), Mouse colon adenocarcinoma, Cancer cell line (CVCL_7254), B16F10 — Mus musculus (Mouse), Mouse melanoma, Cancer cell line (CVCL_0159), 4T1 breast cancer — Homo sapiens (Human), Transformed cell line (CVCL_WC49), U87MG — Homo sapiens (Human), Glioblastoma, Cancer cell line (CVCL_0022), HCC827 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_2063), BT474 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0179), MGC803 — Homo sapiens (Human), Hybrid cell line (CVCL_5334), 4T1 — Mus musculus (Mouse), Malignant neoplasms of the mouse mammary gland, Cancer cell line (CVCL_0125), A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), Hela — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), A431 — Homo sapiens (Human), Skin squamous cell carcinoma, Cancer cell line (CVCL_0037), HCT-116 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_0291), MDA-MB-231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062), MB49 — Mus musculus (Mouse), Mouse bladder transitional cell carcinoma, Cancer cell line (CVCL_7076), MC-38 — Mus musculus (Mouse), Mouse colon adenocarcinoma, Cancer cell line (CVCL_B288)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10534847/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC10534847/full.md

## References

183 references — full list in the complete paper: https://tomesphere.com/paper/PMC10534847/full.md

---
Source: https://tomesphere.com/paper/PMC10534847